J Obes Metab Syndr.
2023 Dec;32(4):285-288. 10.7570/jomes23078.
The Transformative Impact of New Anti-Obesity Medications: A Paradigm Shift in Medical Practice?
- Affiliations
-
- 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
- KMID: 2550375
- DOI: http://doi.org/10.7570/jomes23078
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Next Generation Antiobesity Medications: Setmelanotide, Semaglutide, Tirzepatide and Bimagrumab: What do They Mean for Clinical Practice?
- Long-Term Current Management of Enduring Obesity in Diabetes
- Attitudes and Reported Practice for Obesity Management in Korea After Introduction of Anti-obesity Agents
- Update on Anti-obesity Medications
- The Role of Anti-Obesity Medication in Prevention of Diabetes and Its Complications
